Ben Chang

Ben Chang is CEO, and Director of PhorMed. He is responsible for overseeing the company’s business growth, the advancement of PhorMed’s clinical development programs, and buildout of the company’s pipeline. He has been the driving force behind PhorMed’s patient-focused drug development model, which utilizes patient insights to inform clinical research programs focused on next-generation, innovative treatment to help people living with rare oncological diseases. Ben has 30+ years of experience in clinical medicine followed by 25+ years of experience in the pharmaceutical industry. Prior to PhorMed, Ben held leadership roles at Merch & Co, Cephalon, and ViroPharma.